Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Jun 13, 2023 11:25am
121 Views
Post# 35493719

RE:RE:RE:RE:RE:RE:RE:Low Share Price Because...

RE:RE:RE:RE:RE:RE:RE:Low Share Price Because...

Sure, I can give you my working hypothesis.

they redacted the deal but when the last financing was done, I noticed in the press release it made claim that baxter was giving them a portion of the next possible payment now to help move them along. I also noticed it was done as a convertible debenture so that's what makes me think it will be one down the road... it also makes me think it takes away from whatever they could get...

given that this company spent over 100m and forked over exclusivity for $5 million (and we've spent another 40 million to get to interim enrolment) + a potential future payment down the road leads me to believe that the number is quite low and poorly negotiated. My guess which could be completely wrong... is another 5 million... or let's say 10 to be very optimistic.. minus the 2.5 we already got... leaves us with 2.5 or 7.5... 3-9 months of burn... 

it's just an educated guess. 


you have a better one?

<< Previous
Bullboard Posts
Next >>